List of works - Amir Sherif

B cells in tumor draining lymph nodes act as efficient antigen presenting cells in cancer patients.

scientific article published on 4 November 2015

Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival

scientific article published on 21 January 2020

Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer

scientific article published in 2022

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

scientific article published on January 2007

Clinical activity of sorafenib in a previously treated advanced urothelial cancer patient.

scientific article

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-2

scientific article published on 20 May 2020

Current status of prognostic immunohistochemical markers for urothelial bladder cancer.

scientific article

Detection of immune responses against urinary bladder cancer in sentinel lymph nodes.

scientific article

Detection of micro-metastases by flow cytometry in lymph nodes from patients with penile cancer

scientific article published on 05 October 2018

Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours.

scientific article published on 6 September 2016

Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer.

scientific article published on 23 December 2016

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

scientific article

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

scientific article published on 19 November 2019

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†

scientific article published on 01 November 2019

Editorial comment on: FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.

scientific article published on 18 May 2009

Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy

scientific article published on 23 November 2019

IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity

scientific article published on 30 August 2020

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer.

scientific article published on 20 January 2018

Immune responses against autologous tumor and human papilloma virus in lymph nodes from patients with penile cancer

scientific article published on 10 December 2020

Incidence, survival and mortality trends of bladder cancer in Sweden 1997-2016

scientific article published on 02 July 2019

Increased CD4 T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients

scientific article published on 03 August 2018

Intravesical instillations and cancer-specific survival in patients with primary carcinoma in situ of the urinary bladder.

scientific article published on 29 March 2017

Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe)

scientific article published on 30 May 2019

Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe)

scientific article published on 30 October 2019

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.

scientific article published on 10 April 2017

Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer

scientific article published on 17 July 2018

Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival

scientific article published on 07 June 2019

New Advances of Sentinel Node Detection in Penile Carcinoma with Clinical Implications and a Perspective on Possible Further Research ⬇️

scientific article published on September 15, 2010

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study

scientific article published on 24 April 2019

Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer ⬇️

scientific article published on December 13, 2011

Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study

scientific article published on 22 April 2019

Pilot study of adoptive immunotherapy with sentinel node-derived T cells in muscle-invasive urinary bladder cancer

scientific article published on 04 July 2015

Re: extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study

scientific article published on 01 July 2004

Reply to Santhanam Sundar's Letter to the Editor re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-Invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009–18

scientific article published on 03 May 2012

Response to comment on "multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies".

scientific article

Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report

scientific article

Sentinel node detection in renal cell carcinoma. A feasibility study for detection of tumour-draining lymph nodes.

scientific article

The effects of a physical exercise programme after radical cystectomy for urinary bladder cancer. A pilot randomized controlled trial

scientific article published on 18 November 2013

The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review

scientific article

The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation

scientific article published on 19 November 2019

The long perspective in emergence of neoadjuvant chemotherapy for bladder cancer in Ontario, Canada-space for improvement with regular and organized multidisciplinary team meetings

scientific article published on 01 June 2018

The many flavors of tumor-associated B cells.

scientific article published on 10 June 2013

Thromboembolic events during neoadjuvant chemotherapy in muscle invasive bladder cancer – any correlation to the central venous access? A clinical practice article

scientific article published on 13 January 2022

Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer

scientific article published on 24 August 2018

Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer

scientific article published on 20 April 2018

Treatment of muscle-invasive bladder cancer.

scientific article published on September 2007

Tumour-associated B cells in urothelial urinary bladder cancer

scientific article published on 10 December 2019

Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness

scientific article published on 27 March 2018

Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging

scientific article published on 06 April 2020

Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway.

scientific article published on 2 July 2018

Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma.

scientific article published on 28 May 2014

List of works by Amir Sherif

B cells in tumor draining lymph nodes act as efficient antigen presenting cells in cancer patients.

Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival

Central Venous Access and the Risk for Thromboembolic Events in Patients Undergoing Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

Clinical activity of sorafenib in a previously treated advanced urothelial cancer patient.

Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020) 223-2

Current status of prognostic immunohistochemical markers for urothelial bladder cancer.

Detection of immune responses against urinary bladder cancer in sentinel lymph nodes.

Detection of micro-metastases by flow cytometry in lymph nodes from patients with penile cancer

Detection of micrometastases by flow cytometry in sentinel lymph nodes from patients with renal tumours.

Doxorubicin enhances the capacity of B cells to activate T cells in urothelial urinary bladder cancer.

EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees

EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†

Editorial comment on: FDG-PET/CT for the preoperative lymph node staging of invasive bladder cancer.

Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy

IL-16 processing in sentinel node regulatory T cells is a factor in bladder cancer immunity

Immune Responses to Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer.

Immune responses against autologous tumor and human papilloma virus in lymph nodes from patients with penile cancer

Incidence, survival and mortality trends of bladder cancer in Sweden 1997-2016

Increased CD4 T cell lineage commitment determined by CpG methylation correlates with better prognosis in urinary bladder cancer patients

Intravesical instillations and cancer-specific survival in patients with primary carcinoma in situ of the urinary bladder.

Management and outcome of TaG3 tumours of the urinary bladder in the nationwide, population-based bladder cancer database Sweden (BladderBaSe)

Management and outcome of muscle-invasive bladder cancer with clinical lymph node metastases. A nationwide population-based study in the bladder cancer data base Sweden (BladderBaSe)

Molecular Subgroup of Primary Prostate Cancer Presenting with Metastatic Biology.

Neoadjuvant Chemotherapy Reinforces Antitumour T cell Response in Urothelial Urinary Bladder Cancer

Neoadjuvant chemotherapy for muscle invasive bladder cancer: a nationwide investigation on survival

New Advances of Sentinel Node Detection in Penile Carcinoma with Clinical Implications and a Perspective on Possible Further Research ⬇️

No increased risk of short-term complications after radical cystectomy for muscle-invasive bladder cancer among patients treated with preoperative chemotherapy: a nation-wide register-based study

Pathologic Downstaging Is a Surrogate Marker for Efficacy and Increased Survival Following Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-Invasive Urothelial Bladder Cancer ⬇️

Period-specific mean annual hospital volume of radical cystectomy is associated with outcome and perioperative quality of care: a nationwide population-based study

Pilot study of adoptive immunotherapy with sentinel node-derived T cells in muscle-invasive urinary bladder cancer

Re: extended radical lymphadenectomy in patients with urothelial bladder cancer: results of a prospective multicenter study

Reply to Santhanam Sundar's Letter to the Editor re: Arnulf Stenzl, Nigel C. Cowan, Maria De Santis, et al. Treatment of Muscle-Invasive and Metastatic Bladder Cancer: Update of the EAU Guidelines. Eur Urol 2011;59:1009–18

Response to comment on "multiplex B cell characterization in blood, lymph nodes, and tumors from patients with malignancies".

Sentinel node detection in muscle-invasive urothelial bladder cancer is feasible after neoadjuvant chemotherapy in all pT stages, a prospective multicenter report

Sentinel node detection in renal cell carcinoma. A feasibility study for detection of tumour-draining lymph nodes.

The effects of a physical exercise programme after radical cystectomy for urinary bladder cancer. A pilot randomized controlled trial

The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review

The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation

The long perspective in emergence of neoadjuvant chemotherapy for bladder cancer in Ontario, Canada-space for improvement with regular and organized multidisciplinary team meetings

The many flavors of tumor-associated B cells.

Thromboembolic events during neoadjuvant chemotherapy in muscle invasive bladder cancer – any correlation to the central venous access? A clinical practice article

Tissue-resident memory T cells are epigenetically cytotoxic with signs of exhaustion in human urinary bladder cancer

Treatment according to guidelines may bridge the gender gap in outcome for patients with stage T1 urinary bladder cancer

Treatment of muscle-invasive bladder cancer.

Tumour-associated B cells in urothelial urinary bladder cancer

Urinary Bladder Cancer Tregs Suppress MMP2 and Potentially Regulate Invasiveness

Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging

Urothelial bladder cancer may suppress perforin expression in CD8+ T cells by an ICAM-1/TGFβ2 mediated pathway.

Vascular endothelial growth factor receptor 2, but not S100A4 or S100A6, correlates with prolonged survival in advanced urothelial carcinoma.